Serum concentrations of cortisol, sex hormones of adrenal origin, and adrenocortical steroid intermediates in healthy dogs following stimulation with two doses of cosyntropin.

OBJECTIVE To compare the effects of 2 doses of cosyntropin (5 microg/kg vs 250 microg, IV) on serum concentrations of cortisol, sex hormones of adrenal origin, and adrenocortical steroid intermediates and determine the optimal sample collection time after adrenal stimulation with cosyntropin. ANIMALS 10 healthy, privately owned, neutered dogs. PROCEDURE Dogs were randomly assigned to initially receive cosyntropin at 5 microg/kg or as a total dose of 250 microg, IV. Dogs received the alternate dose 1 to 2 weeks later. Serum was obtained from blood samples collected before (0 minutes) and 30, 60, 90, and 120 minutes after cosyntropin administration. RESULTS Maximum stimulation of cortisol, androstenedione, progesterone, and 17-hydroxyprogesterone production was achieved at 60 minutes following IV administration of cosyntropin at 5 microg/kg or as a total dose of 250 microg. Serum estradiol concentration did not increase in response to either cosyntropin dose. For all hormones, no significant difference in serum hormone concentrations was found among sample collection times of 0, 30, 60, and 90 minutes when comparing the 2 doses of cosyntropin. CONCLUSIONS AND CLINICAL RELEVANCE Cosyntropin, when administered at 5 microg/kg, IV, effectively stimulated maximum production of cortisol, sex hormones of adrenal origin, and adrenocortical steroid intermediates at 1 hour after administration.

[1]  B. Rohrbach,et al.  Retrospective evaluation of sex hormones and steroid hormone intermediates in dogs with alopecia. , 2003, Veterinary dermatology.

[2]  J. West,et al.  Steroid hormone concentration profiles in healthy intact and neutered dogs before and after cosyntropin administration. , 2003, Domestic animal endocrinology.

[3]  E. Heath,et al.  The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism. , 2002, Journal of veterinary internal medicine.

[4]  R. Kemppainen,et al.  Diagnosis of hyperadrenocorticism in dogs: a survey of internists and dermatologists. , 2002, Journal of the American Veterinary Medical Association.

[5]  S. Bulun,et al.  Estrogen production and action. , 2001, Journal of the American Academy of Dermatology.

[6]  R. Denovo,et al.  Cortisol concentrations following stimulation of healthy and adrenopathic dogs with two doses of tetracosactrin. , 2000, The Journal of small animal practice.

[7]  R. Kemppainen,et al.  Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism. , 1999, Journal of the American Veterinary Medical Association.

[8]  E. Norman,et al.  Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia , 1999, Veterinary Record.

[9]  J. Oliver,et al.  Comparison of serum cortisol concentrations in clinically normal dogs after administration of freshly reconstituted versus reconstituted and stored frozen cosyntropin. , 1998, Journal of the American Veterinary Medical Association.

[10]  M. Salman,et al.  Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995). , 1997, Journal of the American Veterinary Medical Association.

[11]  M. Re Screening tests used in the diagnosis of canine hyperadrenocorticism. , 1994 .

[12]  R. Nelson,et al.  Canine and Feline Endocrinology and Reproduction , 1987 .